» Articles » PMID: 8461023

Novel Missense Variants of Prion Protein in Creutzfeldt-Jakob Disease or Gerstmann-Sträussler Syndrome

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1993 Mar 15
PMID 8461023
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

We found 3 novel missense variants in the open reading frame of the prion protein (PrP) gene. The codon 105 point mutation (proline to leucine) was found on a codon 129 (Valine) PrP allele in 4 patients from 3 different Japanese families with Gerstmann-Sträussler syndrome. The codon 180 variant PrP (valine to isoleucine) was found in Creutzfeldt-Jakob disease (CJD) patients with a similar clinical course to that of codon 178 mutation. The codon 232 variant PrP (methionine to arginine) was documented in the CJD patients with typical clinical and pathological findings. These variant PrP molecules were not detected in 200 normal Japanese PrP alleles. PrP has a large repertoire of variant forms, and each primary structure of PrP corresponds to the distinct phenotype of prion diseases.

Citing Articles

A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt-Jakob Disease.

Nonaka T, Ae R, Kosami K, Tange H, Kaneko M, Nakagaki T Diagnostics (Basel). 2024; 14(21).

PMID: 39518392 PMC: 11545003. DOI: 10.3390/diagnostics14212424.


Accumulation Area of a Japanese P102L Variant Associated With Gerstmann-Sträussler-Scheinker Disease: The Ariake P102L Variant.

Suzuyama K, Eriguchi M, Minagawa H, Honda H, Kai K, Kitamoto T J Clin Neurol. 2024; 20(3):321-329.

PMID: 38171504 PMC: 11076189. DOI: 10.3988/jcn.2023.0102.


Cerebral cortex swelling in V180I genetic Creutzfeldt-Jakob disease: comparative imaging study between sporadic and V180I genetic Creutzfeldt-Jakob disease in the early stage.

Muroga Y, Sugiyama A, Mukai H, Hashiba J, Yokota H, Satoh K Prion. 2023; 17(1):105-110.

PMID: 37013454 PMC: 10075330. DOI: 10.1080/19336896.2023.2197809.


Preventive or promotive effects of polymorphic heterozygosity on the onset of prion disease.

Kai H, Teruya K, Takeuchi A, Nakamura Y, Mizusawa H, Yamada M Heliyon. 2023; 9(3):e13974.

PMID: 36915552 PMC: 10006469. DOI: 10.1016/j.heliyon.2023.e13974.


A point mutation in GPI-attachment signal peptide accelerates the development of prion disease.

Kobayashi A, Hirata T, Shimazaki T, Munesue Y, Aoshima K, Kimura T Acta Neuropathol. 2023; 145(5):637-650.

PMID: 36879070 DOI: 10.1007/s00401-023-02553-5.